1	Identification	identification	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	ionomycin/cyclosporin	ionomycin/cyclosporin	_	_	_	_	_	_	_
5	A-responsive	a-responsive	_	_	_	_	_	_	_
6	element	element	_	_	_	_	_	_	_
7	within	within	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cell	cell	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	gamma	gamma	_	_	_	_	_	_	_
14	enhancer	enhancer	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	through	through	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	Ca2+/calcineurin	Ca2+/calcineurin	_	_	_	_	_	_	_
5	pathway	pathway	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	essential	essential	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	transcription	transcription	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	many	many	_	_	_	_	_	_	_
13	cytokine	cytokine	_	_	_	_	_	_	_
14	genes	gene	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	conserved	conserve	_	_	_	_	_	_	_
3	cis-acting	cis-acting	_	_	_	_	_	_	_
4	sequence	sequence	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	GGAAAA	GGAAAA	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	transcription	transcription	_	_	_	_	_	_	_
10	factors	factor	_	_	_	_	_	_	_
11	binding	bind	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	this	this	_	_	_	_	_	_	_
14	sequence	sequence	_	_	_	_	_	_	_
15	are	be	_	_	_	_	_	_	_
16	involved	involve	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	response	response	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	increased	increase	_	_	_	_	_	_	_
22	intracellular	intracellular	_	_	_	_	_	_	_
23	Ca2+	ca2+	_	_	_	_	_	_	_
24	concentrations	concentration	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Here	here	_	_	_	_	_	_	_
2	we	we	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	identification	identification	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	importance	importance	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	same	same	_	_	_	_	_	_	_
11	sequence	sequence	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	non-cytokine	non-cytokine	_	_	_	_	_	_	_
15	gene	gene	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	human	human	_	_	_	_	_	_	_
19	T	t	_	_	_	_	_	_	_
20	cell	cell	_	_	_	_	_	_	_
21	receptor	receptor	_	_	_	_	_	_	_
22	gamma	gamma	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	TCRG	TCRG	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	enhancer	enhancer	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Results	result	_	_	_	_	_	_	_
2	from	from	_	_	_	_	_	_	_
3	site-directed	site-directed	_	_	_	_	_	_	_
4	mutations	mutation	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	electrophoretic	electrophoretic	_	_	_	_	_	_	_
7	mobility	mobility	_	_	_	_	_	_	_
8	shift	shift	_	_	_	_	_	_	_
9	assays	assay	_	_	_	_	_	_	_
10	strongly	strongly	_	_	_	_	_	_	_
11	suggest	suggest	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	this	this	_	_	_	_	_	_	_
14	sequence	sequence	_	_	_	_	_	_	_
15	mediates	mediate	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	ionomycin-induced	ionomycin-induced	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	TCRG	TCRG	_	_	_	_	_	_	_
22	enhancer	enhancer	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	provide	provide	_	_	_	_	_	_	_
4	an	an	_	_	_	_	_	_	_
5	explanation	explanation	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	previous	previous	_	_	_	_	_	_	_
9	observation	observation	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	TCRG	tcrg	_	_	_	_	_	_	_
12	mRNA	mrna	_	_	_	_	_	_	_
13	levels	level	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	mRNA	mrna	_	_	_	_	_	_	_
18	levels	level	_	_	_	_	_	_	_
19	for	for	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cell	cell	_	_	_	_	_	_	_
22	receptor	receptor	_	_	_	_	_	_	_
23	alpha	alpha	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	-beta	-beta	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	are	be	_	_	_	_	_	_	_
28	increased	increase	_	_	_	_	_	_	_
29	by	by	_	_	_	_	_	_	_
30	ionomycin	ionomycin	_	_	_	_	_	_	_
31	treatment	treatment	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

